Using the assay of [3H]ryanodine binding to the sarcoplasmic reticulum, the effect of Zn2+ on ryanodine receptors (RyRs) of cardiac muscle was investigated. There was no obvious change in the binding at [Zn2+]f of less than 0.2 µM. However, a decrease of the binding became significant with raising [Zn2+]f to 0.5 µM. The inhibitory effect of Zn2+ was [Zn2+]f-dependent, with IC50/ZnI of 2.1±0.4 µM (mean±S.D.). Scatchard analysis indicates that both an increase of Kd and a decrease of Bmax were responsible for Zn2+-induced decrease of the binding. The Hill coefficient for this inhibitory effect of Zn2+ was between 0.8 and 1.2. The interactions of the effects of Zn2+ and various modulators of RyR indicate that the inhibitory effect of Zn2+ was mostly mediated through inhibiting Ca2+ activation sites (CaA) on RyR. Since the [Zn2+]f dependence was not clearly changed by [Ca2+]f, the inhibitory effect of Zn2+ may not be due to competition of Zn2+ with Ca2+ for CaA and probably is indirect. The inhibitory effect of Zn2+ could not be antagonized by 2 mM dithiothreitol, a thiol-reducing agent, suggesting that the binding of Zn2+ ions to RyRs of cardiac muscle is not accompanied by obvious change of redox state of the RyRs. In comparison with that seen in skeletal muscle [3], the effects of Zn2+ on ryanodine binding to the sarcoplasmic reticulum of cardiac muscle show several distinct differences. It is indicated that the effect of Zn2+ on RyRs may be isoform-dependent. The physiological significance of the effects of Zn2+ is discussed.